Resmed (RSMDF) Amortizatization of Intangibles (2021 - 2026)
Resmed's (RSMDF) quarterly Amortizatization of Intangibles came in at $10.3 million in Q2 2026, down 2.97% on a YoY basis from $10.7 million in Q2 2025, and up 2.91% quarter-over-quarter from $10.1 million in Q1 2026.
Analysis
Resmed (RSMDF) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Amortizatization of Intangibles for 6 consecutive years, with $10.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortizatization of Intangibles fell 2.97% year-over-year to $10.3 million; the trailing twelve-month figure through Jun 2026 stood at $42.8 million (up 14.66% YoY), and the FY2026 full-year result was $42.8 million, up 14.66% from the prior year.
- Amortizatization of Intangibles climbed to $10.3 million in Q2 2026 per RSMDF's latest filing, from $10.1 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $12.4 million in Q4 2025 and bottomed at $7.6 million in Q2 2022.
- Historically, Amortizatization of Intangibles has averaged $9.4 million across 5 years, with a median of $9.1 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 32.42% in 2024, then fell 26.26% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $7.8 million in 2022, then rose by 10.47% to $8.6 million in 2023, then climbed by 10.21% to $9.5 million in 2024, then soared by 31.51% to $12.4 million in 2025, then retreated by 16.89% to $10.3 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $10.3 million, $10.1 million, and $12.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | - |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 10.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.34 Mn |
| Mar 31, 2026 | 10.05 Mn |
| Dec 31, 2025 | 12.45 Mn |
| Sep 30, 2025 | 9.97 Mn |
| Jun 30, 2025 | 10.66 Mn |
| Mar 31, 2025 | 8.24 Mn |
| Dec 31, 2024 | 9.46 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 11.08 Mn |
| Mar 31, 2024 | 11.17 Mn |
| Dec 31, 2023 | 8.59 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 8.44 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 7.76 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 9.30 Mn |
| Dec 31, 2021 | 8.82 Mn |
| Sep 30, 2021 | 8.52 Mn |